Lataa...
Enhanced brain accumulation of pazopanib by modulating P-gp and Bcrp1 mediated efflux with canertinib or erlotinib
Primary objective of this investigation was to delineate the differential impact of efflux transporters P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp1/Abcg2) on brain disposition and plasma pharmacokinetics of pazopanib. In addition, this research investigated whether inhibi...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3573846/ https://ncbi.nlm.nih.gov/pubmed/22688250 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpharm.2012.05.038 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|